Cellular prion protein contributes to LS 174T colon cancer cell carcinogenesis by increasing invasiveness and resistance against doxorubicin-induced apoptosis
Authors:
- 17 May 2015
- journal article
- Published by Springer Nature in Tumor Biology
- Vol. 36 (10) , 8107-8120
Abstract
As the cellular prion protein (PrPC) has been implicated in carcinogenesis, we aimed to investigate the effects of cancer cell-specific PrPC overexpression from the invasion, metastasis, and apoptosis aspects, by performing cell motility assays, cell proliferation assays under anchorage-dependent and anchorage-independent conditions, and apoptosis evasion when subjected to multiple anti-cancer drugs. Overexpression of PrPC in LS 174T was achieved by stable transfection. PrPC overexpression was shown to increase cell proliferation in anchorage-dependent and anchorage-independent manners, as shown by more viable cells in 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, more colonies formed in soft agar assay and increased resistance to anoikis in poly-2-hydroxyethyl methacrylate-coated surface. PrPC overexpression also increased cell motility and invasiveness of LS 174T. Cell adhesion to extracellular matrix using collagen- and fibronectin-coated surfaces revealed increased cell attachment in LS 174T cells overexpressing PrPC. Analysis of apoptotic and necrotic cells by propidium iodide/annexin V-fluorescein isothiocyanate microscopy and 7-amino-actinomycin D/annexin V-phycoerythrin flow cytometry revealed that PrPC overexpression attenuated doxorubicin-induced apoptosis. Human apoptosis antibody array with 35 apoptosis-related proteins revealed that three inhibitor of apoptosis proteins (IAPs)—survivin, X-linked inhibitor of apoptosis protein (XIAP), and cellular inhibitor of apoptosis protein-1 (cIAP-1)—were upregulated in LS 174T cells overexpressing PrPC in doxorubicin-induced apoptosis. In conclusion, the overexpression of PrPC could enhance the invasiveness and survival of LS 174T colorectal cancer cells, indicating that PrPC plays a role in colorectal cancer biology.Keywords
This publication has 43 references indexed in Scilit:
- Silencing Prion Protein in MDA-MB-435 Breast Cancer Cells Leads to Pleiotropic Cellular Responses to Cytotoxic StimuliPLOS ONE, 2012
- Differences in integrin expression and signaling within human breast cancer cellsBMC Cancer, 2011
- The multiple functions of cytochrome c and their regulation in life and death decisions of the mammalian cell: From respiration to apoptosisMitochondrion, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Inhibition of telomerase activity by HDV ribozyme in cancersJournal of Experimental & Clinical Cancer Research, 2011
- Pro-prion Binds Filamin A, Facilitating Its Interaction with Integrin β1, and Contributes to MelanomagenesisJournal of Biological Chemistry, 2010
- Binding of pro-prion to filamin A disrupts cytoskeleton and correlates with poor prognosis in pancreatic cancerJournal of Clinical Investigation, 2009
- Silencing of Prion Protein Sensitizes Breast Adriamycin-Resistant Carcinoma Cells to TRAIL-Mediated Cell DeathCancer Research, 2007
- Mitochondrial Membrane Permeabilization in Cell DeathPhysiological Reviews, 2007
- Cell DeathCell, 2004